194 related articles for article (PubMed ID: 23029301)
1. Eicosapentaenoic acid and oxypurinol in the treatment of muscle wasting in a mouse model of cancer cachexia.
Vaughan VC; Sullivan-Gunn M; Hinch E; Martin P; Lewandowski PA
PLoS One; 2012; 7(9):e45900. PubMed ID: 23029301
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
[TBL] [Abstract][Full Text] [Related]
3. MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia.
Zhang L; Tang H; Kou Y; Li R; Zheng Y; Wang Q; Zhou X; Jin L
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1105-15. PubMed ID: 23535871
[TBL] [Abstract][Full Text] [Related]
4. The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy.
Springer J; Tschirner A; Hartman K; von Haehling S; Anker SD; Doehner W
Int J Cardiol; 2013 Oct; 168(4):3527-31. PubMed ID: 23751350
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
6. Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice.
Smith HJ; Greenberg NA; Tisdale MJ
Br J Cancer; 2004 Jul; 91(2):408-12. PubMed ID: 15213711
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy.
Jho DH; Babcock TA; Tevar R; Helton WS; Espat NJ
JPEN J Parenter Enteral Nutr; 2002; 26(5):291-7. PubMed ID: 12216709
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase contributes to mechanical ventilation-induced diaphragmatic oxidative stress and contractile dysfunction.
Whidden MA; McClung JM; Falk DJ; Hudson MB; Smuder AJ; Nelson WB; Powers SK
J Appl Physiol (1985); 2009 Feb; 106(2):385-94. PubMed ID: 18974366
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic Acid-Enriched Phospholipids Alleviate Skeletal Muscle Atrophy in Lewis Lung Carcinoma Mouse Model.
Wu ZJ; Li WH; Yang YH; Zheng Y; Zhou MQ; Li YC; Li H; Wu H; Du L
Mol Nutr Food Res; 2023 Jul; 67(13):e2300033. PubMed ID: 37128748
[TBL] [Abstract][Full Text] [Related]
10. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
11. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
[TBL] [Abstract][Full Text] [Related]
13. Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice.
Hinch EC; Sullivan-Gunn MJ; Vaughan VC; McGlynn MA; Lewandowski PA
J Cachexia Sarcopenia Muscle; 2013 Dec; 4(4):287-93. PubMed ID: 24030522
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia.
Tisdale MJ
Nutrition; 1996 Jan; 12(1 Suppl):S31-3. PubMed ID: 8850217
[TBL] [Abstract][Full Text] [Related]
15. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
16. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C
Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.
Tseng YC; Kulp SK; Lai IL; Hsu EC; He WA; Frankhouser DE; Yan PS; Mo X; Bloomston M; Lesinski GB; Marcucci G; Guttridge DC; Bekaii-Saab T; Chen CS
J Natl Cancer Inst; 2015 Dec; 107(12):djv274. PubMed ID: 26464423
[TBL] [Abstract][Full Text] [Related]
18. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment of carfilzomib and z-VAD-fmk inhibits skeletal proteolysis and apoptosis and ameliorates cancer cachexia.
Wang Q; Li C; Peng X; Kang Q; Deng D; Zhang L; Zheng Y; Wang C; Qiao Z; Guo D; You S; Tang H
Med Oncol; 2015 Apr; 32(4):100. PubMed ID: 25737433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
